To answer this question, we examined the expression level changes to MAP2K6 in 60 pairs NSCLC tissues and paracancerous tissues by qRT-PCR assay and observed the effects of MAP2K6 knockdown on NSCLC growth by xenograft experiments. The gene discussed is MAP2K6; the disease is non-small cell lung carcinoma.